GSS — Genetic Signatures Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$121.21m
- AU$103.10m
- AU$22.06m
- 31
- 26
- 75
- 44
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.168 | 0.129 | 0.326 | 0.126 | 0.565 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.27 | -9.49 | 4.2 | 9.81 | -12.5 |
Capital Expenditures | -0.611 | -2.35 | -4.98 | -2.99 | -8.09 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -0.611 | -2.35 | -4.98 | -2.99 | -8.09 |
Financing Cash Flow Items | -0.006 | -1.89 | -0.012 | -0.009 | -0.001 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.25 | 36.7 | -0.19 | -0.101 | -0.023 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.64 | 24.9 | -1.05 | 6.78 | -20.5 |